Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by 2quick154on Aug 23, 2017 11:47am
139 Views
Post# 26612381

RE:Management issue?

RE:Management issue?Couldn't agree more - trying to run / start trials for PG: Diabetic Foot Ulcers, Tympanic Repair, Critical Care.

IVIG Trial
4050 for IPF, CKD, Alstrom, Metabolic Syndrome, Cystic Fibrosis
4057 entering trials soon

Not to mention ramping up production for approval of PG...

Doing ALL of this with 6 months of cash... now when we will need cash, our SP will be what... $1 ?

Stop trying to re-invent the wheel PL... should have taken partners and $$ in the bank along time ago.
Bullboard Posts